Liver Disease

Liver Disease Tests help identify liver injury, measure how well the liver works, and look for common causes such as viral hepatitisfatty liver (metabolic)alcohol-related diseaseautoimmune conditions, and genetic disorders. Because early liver disease is often silent, proactive testing can catch problems sooner and guide next steps.

A smart starting point is a hepatic function panel (AST, ALT, alkaline phosphatase, GGT, total/direct bilirubin, albumin, total protein) plus PT/INRplatelets/CBC, and basic kidney/sodium for safety. Add hepatitis B/C panelsautoimmune markers (ANA, ASMA, AMA), iron studiesceruloplasmin (Wilson disease), and alpha-1 antitrypsin when patterns or risks suggest them. Noninvasive fibrosis scores calculated from routine labs (FIB-4, APRI; ELF where available) help estimate scarring risk. Labs support screeningdiagnosisstaging, and monitoring, but do not replace a clinician’s exam, ultrasound/elastography, or endoscopy when needed.

Signs, Symptoms & Related Situations

  • Often silent early: abnormal labs on a routine panel

  • Skin/eyes & digestion: jaundice, dark urine, pale stools, itching, poor appetite, nausea

  • Abdomen & fluid: bloating or ascites, rapid weight change, leg swelling

  • Bleeding/energy: easy bruising/bleeding, fatigue, weakness

  • Thinking changes: trouble concentrating, sleep reversal, confusion (possible encephalopathy)

  • Risks & exposures: viral hepatitis, alcohol, metabolic syndrome (central weight, diabetes, high triglycerides), family history of iron/copper/A1AT disorders, autoimmune disease, certain medications/supplements

  • Urgent care now: vomiting blood or black stools, severe abdominal swelling with pain/fever, confusion, chest pain, or trouble breathing

All symptoms and risks should be reviewed by a qualified clinician.

Why These Tests Matter

What testing can do

  • Reveal injury patterns (hepatocellular vs. cholestatic) and synthetic function (albumin, INR)

  • Help identify causes (hepatitis viruses, autoimmune markers, iron/copper/A1AT abnormalities)

  • Provide risk clues for scarring using platelets and calculated fibrosis scores (FIB-4/APRI/ELF)

  • Track trends to guide follow-up timing and imaging

What testing cannot do

  • Confirm cirrhosis or cancer on labs alone—imaging/elastography (and sometimes biopsy) may be needed

  • Replace a clinician’s exam, medication/alcohol review, or nutrition counseling

  • Provide treatment or dosing advice—use results to plan with your clinician

What These Tests Measure (at a glance)

  • AST & ALT: enzymes of liver cell injury; ALT is more liver-specific.

  • Alkaline Phosphatase (ALP) & GGT: markers of cholestasis; GGT helps confirm a liver source when ALP is high.

  • Bilirubin (total/direct): high levels cause jaundice; patterns suggest blockage vs. overproduction.

  • Albumin & Total Protein (± A/G ratio): reflect synthetic function and nutrition/inflammation context.

  • PT/INR: clotting proteins made by the liver; prolonged INR indicates reduced synthesis.

  • Platelets & CBC: low platelets can point to portal hypertension; CBC adds anemia/infection context.

  • Basic metabolic panel (sodium, creatinine/eGFR): overall safety; components feed risk scores.

  • Hepatitis testing: HBsAg, anti-HBs, anti-HBcHCV Ab with reflex RNAHAV IgM/totalHDV/HEV in select cases.

  • Autoimmune markers: ANA, ASMA, AMAIgG/IgM—support autoimmune hepatitis or primary biliary cholangitis patterns.

  • Iron & genetics: Ferritin, iron/TIBC, transferrin saturation (hemochromatosis risk); HFE testing per clinician.

  • Wilson & A1AT: Ceruloplasmin (± copper studies) for Wilson disease; alpha-1 antitrypsin level/phenotype for A1AT deficiency.

  • Metabolic risk: A1clipid panel for fatty liver risk.

  • Fibrosis estimation: FIB-4, APRI (from age, AST, ALT, platelets), ELF where available.

  • HCC marker (context): AFP may support surveillance programs alongside ultrasound.

Quick Build Guide

Clinical goal Start with Add if needed
Abnormal liver enzymes Liver panel • PT/INR • Platelets/CBC • BMP (Na, creatinine) HBV/HCV panels • Ferritin/Iron/TIBC • A1c/Lipids • ANA/ASMA/AMA
Fatty liver risk (metabolic) AST/ALT • GGT • Platelets • Albumin • A1c • Lipids Calculate FIB-4/APRI; rule out HBV/HCV
Cholestatic pattern (ALP/GGT high) Liver panel • Direct bilirubin AMA • IgM (PBC context); clinician-directed imaging
Possible alcohol-related pattern AST/ALT • GGT • Platelets • INR • Albumin Hepatitis panels • Ferritin; discuss alcohol history with clinician
Unclear cause Liver panel • PT/INR • CBC HBV/HCV • Ferritin/Iron/TIBC • Ceruloplasmin • A1AT • ANA/ASMA/AMA
Monitoring known liver disease Bilirubin • INR • Creatinine • Sodium • Albumin • Platelets AFP for HCC surveillance; trend MELD-type labs

How the Testing Process Works

  1. Choose your starting set: most users begin with a hepatic function panelPT/INRCBC/platelets, and BMP.

  2. Add cause-finding labs: based on history and patterns, include hepatitis panelsautoimmune markers, and iron/copper/A1AT studies.

  3. Provide a blood sample: no routine fasting (fast only for lipids). List all medicines and supplements on your order.

  4. Get results securely: most values post within a few days.

  5. Plan next steps: your clinician may recommend ultrasound/FibroScan, MRI, or endoscopy. Recheck at set intervals to monitor trends.

Interpreting Results (General Guidance)

  • AST/ALT predominant elevation: hepatocellular injury (e.g., viral hepatitis, metabolic/fatty liver, alcohol, medication).

  • ALP ± GGT predominant elevation: cholestasis or bile-duct disease.

  • Rising bilirubin, high INR, low albumin: reduced synthetic function—closer follow-up needed.

  • Low platelets: may reflect portal hypertension; correlate with imaging and exam.

  • High ferritin with high transferrin saturation: consider iron overload; discuss HFE testing.

  • Low ceruloplasmin (younger patients): consider Wilson disease with clinician guidance.

  • High FIB-4/APRI: suggests advanced fibrosis; confirm with elastography.
    Always interpret results with a qualified healthcare professional; patterns and trends matter more than any single value.

Choosing Panels vs. Individual Tests

  • Foundational liver set: Liver panel • PT/INR • CBC/Platelets • BMP (Na, creatinine)

  • Cause-finding add-ons: HBV/HCV panels • ANA/ASMA/AMA • Ferritin/Iron/TIBC • Ceruloplasmin • Alpha-1 Antitrypsin • A1c/Lipids

  • Fibrosis staging: calculate FIB-4/APRI (± ELF where available); imaging remains key

  • Monitoring: repeat bilirubin, INR, creatinine, sodium, albumin, platelets; add AFP per surveillance plans

FAQs

Do I need to fast for liver tests?
No. Fast only if your order includes lipids.

Can medications or supplements change my results?
Yes. Many drugs and some supplements affect liver enzymes. List everything you take on the order.

Are normal liver tests a clean bill of health?
Not always. Compensated liver disease can have near-normal labs; risk-based monitoring still matters.

What’s the difference between LFTs and “liver function”?
“LFTs” include injury markers (AST/ALT, ALP/GGT) and function markers (albumin, INR). Both are useful.

What is FIB-4?
noninvasive fibrosis score calculated from age, AST, ALT, and platelets; high values suggest more scarring.

Do labs alone diagnose cirrhosis?
No. Labs support the diagnosis; ultrasound/elastography (and sometimes biopsy) confirm stage.

How often should I recheck labs?
Timing depends on results and risk. Many people recheck every 3–12 months—follow your clinician’s plan.

Related Categories & Key Tests

  • Liver & Gallbladder Tests Hub

  • Hepatic Function Tests • Hepatitis Screening Tests • Cirrhosis Tests • Fatty Liver (Metabolic) • Autoimmune Liver Disease • Hemochromatosis • Wilson’s Disease

  • Key Tests : AST • ALT • Alkaline Phosphatase • GGT • Total/Direct Bilirubin • Albumin • Total Protein • PT/INR • Platelets/CBC • Sodium • Creatinine/eGFR • HBsAg • Anti-HBs • Anti-HBc • HCV Ab ± RNA • ANA • ASMA • AMA • Ferritin • Iron/TIBC • Transferrin Saturation • Ceruloplasmin • Alpha-1 Antitrypsin Level/Phenotype • A1c • Lipid Panel • FIB-4/APRI (calculated) • ELF (where available) • AFP

References

  • American Association for the Study of Liver Diseases (AASLD) — Guidance on evaluation of abnormal liver chemistries and chronic liver diseases.
  • AASLD — Guidance on MASLD/NAFLD, autoimmune liver disease, and cholestatic disease.
  • European Association for the Study of the Liver (EASL) — Clinical practice guidelines on liver disease assessment and fibrosis.
  • World Health Organization — Hepatitis B and C testing guidelines.
  • U.S. Preventive Services Task Force — Screening for Hepatitis B and C.
  • Clinical reviews on noninvasive fibrosis scores (FIB-4, APRI, ELF) and laboratory monitoring in liver disease.

Available Tests & Panels

Your Liver Disease Tests menu is pre-populated in the Ulta Lab Tests system. Use filters to build the right package—hepatic function panelPT/INRCBC/plateletsBMP, plus hepatitis panelsautoimmune markersiron/copper/A1AT studies, and fibrosis scoring support. Review results with your clinician to plan imaging, follow-up timing, and ongoing monitoring.

  • Page
  • 1
  • of
  • 5
  • Total Rows
  • 113
Name Matches
Blood
Blood Draw, Phlebotomist

Blood
Blood Draw, Phlebotomist

Blood, Varied
Blood Draw, Phlebotomist

Blood, Varied
Blood Draw, Phlebotomist

The Acetaminophen Test measures the level of acetaminophen (paracetamol) in the blood to evaluate potential overdose, toxicity, or therapeutic monitoring. It helps clinicians assess liver function, determine the extent of drug exposure, and guide timely treatment decisions in cases of suspected acetaminophen poisoning or impaired medication clearance.

Blood
Blood Draw

The Albumin Test measures albumin, the main protein made by the liver that maintains fluid balance and transports hormones, vitamins, and medications. Low albumin may indicate liver disease, kidney problems, malnutrition, or chronic inflammation, while high levels may reflect dehydration. Doctors order this test to evaluate swelling, fatigue, or abnormal labs. Results provide key insight into nutritional status, liver and kidney function, and overall metabolic health.

Blood
Blood Draw
Also Known As: ALB Test

The ALP Test measures alkaline phosphatase enzyme levels in blood to evaluate liver, bone, and bile duct health. High ALP may indicate liver disease, bile duct obstruction, bone disorders, or certain cancers, while low levels may suggest malnutrition or deficiency. Doctors order this test to investigate symptoms like fatigue, abdominal pain, or bone pain and often pair it with other liver function tests. Results provide key insight into metabolic and organ health.

Blood
Blood Draw
Also Known As: Alkaline Phosphatase Test, Alk Phos Test, Alkp Test

The Alkaline Phosphatase Isoenzymes Test measures different forms of alkaline phosphatase (ALP) in the blood to determine their source, such as liver, bone, intestine, or placenta. Doctors use this test to evaluate abnormal ALP results, identify liver disease, bile duct obstruction, bone disorders like Paget’s disease, or certain cancers. It helps distinguish between conditions and guides accurate diagnosis and treatment planning.


The Alpha-1 Antitrypsin Random Feces Test measures levels of alpha-1 antitrypsin, a protein that normally remains in the bloodstream. Elevated amounts in stool suggest protein-losing enteropathy, intestinal inflammation, or gastrointestinal conditions that impair absorption. By evaluating protein loss through the digestive tract, this test helps assess intestinal integrity and overall digestive health.

Varied
Phlebotomist
Also Known As: Alpha-1 Antitrypsin Test, A1AT Test, AAT Test, Alpha-1 Antitrypsin Feces Test

The Alpha-1-Antitrypsin Quantitative Test measures levels of alpha-1-antitrypsin (AAT), a protein that protects the lungs and liver from damage. Low levels may indicate alpha-1-antitrypsin deficiency, a genetic disorder linked to emphysema, COPD, and liver disease. Doctors use this test to investigate unexplained lung or liver problems, confirm hereditary AAT deficiency, and guide treatment or monitoring strategies for long-term health management.

Blood
Blood Draw
Also Known As: Alpha-1 Antitrypsin Test, A1AT Test, AAT Test, Alpha-1 Antitrypsin Serum Test

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

Blood
Blood Draw
Also Known As: AFP Test, Total AFP Test, Alpha-Fetoprotein Tumor Markers, Alpha-Fetoprotein Test

The ALT Test measures alanine aminotransferase, an enzyme mainly found in the liver. Elevated ALT may indicate liver damage from hepatitis, fatty liver disease, cirrhosis, alcohol use, or medication effects. Doctors order this test to evaluate symptoms such as fatigue, abdominal pain, or jaundice and often pair it with AST for accurate liver assessment. Results provide essential insight into liver health, enzyme activity, and overall metabolic function.

Blood
Blood Draw
Also Known As: Alanine Aminotransferase Test, GPT Test, SGPT Test, Serum Glutamic Pyruvic Transaminase Test

The Ammonia Plasma Test measures ammonia levels in blood to evaluate liver function and metabolic health. Elevated ammonia may result from liver disease, cirrhosis, Reye’s syndrome, or urea cycle disorders, causing confusion or altered mental status. Doctors order this test for patients with unexplained behavioral changes, lethargy, or suspected hepatic encephalopathy. Results provide key insight into liver function, metabolic disorders, and treatment monitoring.

Blood
Blood Draw
Also Known As: NH3 Test, NH3 Plasma Test, Ammonia Blood Test

Most Popular

The Amylase Test measures amylase enzyme levels in blood to evaluate pancreatic and digestive health. Elevated amylase may indicate pancreatitis, gallbladder disease, intestinal blockage, or salivary gland disorders, while low levels may suggest chronic pancreatitis or liver damage. Doctors order this test to investigate abdominal pain, nausea, or fever. Results provide vital insight into pancreatic function, digestive disorders, and overall metabolic health.

Blood
Blood Draw
Also Known As: Amy Test

The ANA Screen IFA with Reflex to Titer and Pattern Test detects antinuclear antibodies in blood to evaluate autoimmune activity. If positive, further testing identifies antibody concentration (titer) and fluorescence pattern, helping diagnose conditions like lupus, rheumatoid arthritis, or Sjögren’s syndrome. Doctors order this test to investigate symptoms such as joint pain, fatigue, rash, or swelling and to guide treatment for autoimmune and connective tissue disorders.

Also Known As: ANA Test, Antinuclear Antibody Screen Test

The ANA IFA Panel Comprehensive screens for autoimmune disorders by detecting antinuclear antibodies and specific markers including dsDNA, Sm, Sm/RNP, Scl-70, and Sjögren’s SS-A/SS-B. Doctors order this panel for patients with joint pain, rash, fatigue, or suspected lupus, scleroderma, or Sjögren’s syndrome. Results provide critical insight into autoimmune activity, helping confirm diagnosis, monitor disease progression, and guide treatment decisions.

Also Known As: Comprehensive ANA Panel

The ANCA Screen with Reflex to ANCA Titer detects antineutrophil cytoplasmic antibodies, often linked to autoimmune vasculitis such as granulomatosis with polyangiitis and microscopic polyangiitis. If the screen is positive, a titer is performed to measure antibody levels for greater diagnostic accuracy. Doctors use this test to evaluate unexplained inflammation, kidney or lung issues, and guide treatment decisions in autoimmune and systemic vasculitis care.

Blood
Blood Draw
Also Known As: ANCA Test, cANCA Test, pANCA Test, Serine Protease 3 Test, Acticytoplasmic Test, 3-ANCA test, PR3-ANCA Test, MPO-ANCA test

The AST Test measures aspartate aminotransferase, an enzyme found in the liver, heart, muscles, and other tissues. Elevated AST may indicate liver disease, heart attack, muscle injury, or other organ damage. Doctors order this test to evaluate symptoms such as fatigue, weakness, or jaundice and often pair it with ALT for accurate liver assessment. Results provide key insight into liver function, muscle health, and overall metabolic balance.

Blood
Blood Draw
Also Known As: Aspartate Aminotransferase Test, Serum Glutamic-Oxaloacetic Transaminase Test, SGOT Test

Random
Phlebotomist

The Bile Acids Fractionated and Total Test measures both individual bile acid fractions and total bile acid concentration to evaluate liver function, bile flow, and metabolic integrity. This analysis helps detect cholestasis, hepatocellular injury, or impaired bile acid metabolism, supporting assessment of liver disorders, intrahepatic cholestasis of pregnancy, and other hepatobiliary conditions.

Blood
Blood Draw
Also Known As: Bile Acids Test


The Fractionated Bilirubin Test separates total bilirubin into direct and indirect forms to assess liver and blood health. Elevated direct bilirubin may point to hepatitis, cirrhosis, or bile duct obstruction, while elevated indirect levels can signal hemolytic anemia or inherited disorders. Doctors order this test for jaundice, anemia, or suspected liver conditions. Results help guide diagnosis, treatment, and monitoring of liver and blood disorders.

Blood
Blood Draw
Also Known As: Fractionated Bilirubin Test

The Bilirubin Total Test measures the overall level of bilirubin in blood to assess liver function, red blood cell breakdown, and bile duct health. Elevated bilirubin may cause jaundice and indicate hepatitis, cirrhosis, gallstones, or hemolytic anemia. Doctors order this test for patients with yellowing skin, fatigue, or abnormal liver results. Results provide essential insight into liver disease, blood disorders, and bile flow problems, guiding diagnosis and treatment.

Blood
Blood Draw
Also Known As: Total Bilirubin Test

The BUN Creatinine Ratio Test compares blood urea nitrogen (BUN) to creatinine levels to assess kidney function and hydration status. A high ratio may indicate dehydration, gastrointestinal bleeding, or high protein intake, while a low ratio can suggest liver disease or malnutrition. Doctors order this test with kidney panels to evaluate fatigue, swelling, or abnormal lab results. Results help diagnose renal issues and guide treatment planning.

Blood
Blood Draw
Also Known As: Blood Urea Nitrogen to Creatinine Ratio

The C-Reactive Protein (CRP) Test measures CRP levels in blood to detect inflammation in the body. Elevated CRP may indicate infections, autoimmune disorders, or chronic diseases such as arthritis, cardiovascular disease, or inflammatory bowel disease. Doctors use this test to assess acute illness, monitor treatment response, and evaluate risk for heart disease. The CRP test provides key insight into inflammation, immune health, and overall wellness.

Blood
Blood Draw
Also Known As: CRP Test, Inflammation Test

On the right side of the body, located on the upper side of the abdomen, is the liver. Approximately the size of a football, the liver weighs about 2 to 3 pounds and works to do a variety of functions in the body, including the following:

  • Metabolize and detox harmful substances in the body
  • Convert nutrients that are derived from food into the vital blood components
  • Regulate the body’s ability to clot blood
  • Produce proteins and enzymes
  • Maintain the hormonal balance
  • Store specific vitamins
  • Contribute to the factors that aid in fighting the immune system
  • Remove toxic bacteria from the blood
  • Create bile that is vital for digestion

Bile is a green-yellow fluid that is comprised of bile acids or salts that are created via waste products like bilirubin that are created as red blood cells break down. This then flows through the small bile ducts that are located inside of the liver. Bile moves from the smaller sized ducts into the larger ones much in the same way that streams flow into a river and eventually converge into the main ducts and then exit the liver as the streams exit into a river. Part of the bile will then flow into the duodenum; the rest of the bile will flow into a storage facility and concentrate in the gallbladder. After eating, the gallbladder will then release some of the bile into the smaller sized intestine where it will then digest fats.

Any condition that causes liver inflammation or damage is liver disease. These conditions may also affect how the liver functions. Liver disease is categorized according to the cause and effect upon the liver. Causes can include things such as infection, exposure to drugs, exposure to toxic compounds, injury to the liver, autoimmune processes, genetic defects, and other conditions that may be due to deposits and build-up of metals in the liver, including iron and copper. The residual effects of such exposure are inflammation, injury, obstruction, scarring, abnormalities in blood clotting, and eventual liver failure.

Signs And Symptoms

In the beginning, liver disease may not have any signs or symptoms. Other symptoms may be quite non-specific. Weakness, lack of energy, and other symptoms may also present.

The most typical signs of acute liver disease include the following:

  • Yellowing of skin due to issues processing the bilirubin. These include jaundice, light stools, dark urine, and loss of appetite.
  • Nausea
  • Diarrhea
  • Vomiting

In addition to the conditions mentioned above, Chronic Conditions of liver disease may also include the following:

  • Itching or pruritus
  • Abdominal swelling (ascites)
  • Unexplained weight gain or loss
  • Abdominal pain

These symptoms typically present at a later stage of the disease.

General Laboratory Tests For Liver Disease

The main goal in screening for liver disease is to detect injury to the liver, evaluate the severity of the injury, and diagnose the cause. With time, these will then be monitored to watch for changes.

Early detection and screening are vital to the severity of symptoms, and many can be controlled if caught in time. The more that healthcare professionals can determine the severity, the more they can plan a care plan for managing the symptoms. The liver is fully capable of repairing injuries and in resolving inflammation if the bile ducts aren’t blocked. Blocked bile ducts can lead to cirrhosis and be permanent conditions that will lead to progressive liver damage. It’s important to monitor the status with time to help take any steps that will preserve the function of the liver.

General tests in the laboratory will measure the enzyme levels, protein, bilirubin, and other symptoms if there is an injury present.

Taking a comprehensive metabolic panel or CMP is a series of tests that are done in conjunction with general health screening. This includes several tests that will show the liver function.

A liver panel may also be ordered if there are any abnormalities in the CMP testing process results. These are done if there is any question on liver function or if there has been a liver injury.

Whenever there are abnormal test results, these tests may be administered for further evaluation of the liver. All these tests may also be administered individually to monitor a person who has been diagnosed with a liver condition. These tests may include the following:

Alanine aminotransferase or ALT. This is an enzyme that is mainly located in the liver and can also detect hepatitis.

Alkaline phosphatase or ALP. This enzyme is located in the bile ducts and liver and will increase if they are blocked.

Aspartate aminotransferase or AST. This enzyme is in the liver and other areas of the body, including the heart.

Gamma-glutamyl transferase or GGT. This enzyme is sensitive to changes in the liver status if the bile ducts are blocked.

Total bilirubin will measure the amount of bilirubin in the blood. The levels will be higher for many liver conditions.

Direct bilirubin will measure the type of bilirubin that is combined with other compounds and increases if liver disease is present.

Albumin is the main protein that is manufactured in the liver. It will tell how the liver is doing.

Total protein will measure the amount of the protein in the liver as well as the antibodies that are present to help ward off infections.

Lactate dehydrogenase or LDH. This enzyme is released with damaged tissue and may raise if there is acute liver disease.

Select Tests

Several tests may be ordered to diagnose liver dysfunction. Some are used to monitor the condition and others to diagnose.

Liver Biopsy: Small samples of the liver tissue are taken to evaluate the liver and the cells.

Ammonia: This could be elevated in the later stages of cirrhosis and liver failure.

Viral Hepatitis tests (A, B, And C): to detect viral infections in the liver.

Alpha-fetoprotein or AFP: will elevate with liver cancer.

Des-gamma-carboxy prothrombin or DCP: will also elevate with liver cancer.

Prothrombin time or PT: will show clotting function.

Iron tests: Hemochromatosis or iron metabolism disorders

Copper and Ceruloplasmin: Wilson’s Disease is a genetic copper metabolism disorder

Alpha 1 antitrypsin: will test for deficiency.

Antimitochondrial antibody or AMA: will diagnose biliary cholangitis or PBC.

There are tests for autoantibodies that will help to diagnose autoimmune hepatitis, including antinuclear antibodies or ANA. Antismooth muscle antibodies or ASMA and the F-actin antibodies for both liver and kidney microsomes or anti-LKM1. Acetaminophen levels and other overdose drug tests or if the person is doing drugs will also show.

CBC or complete blood count will show elevated white and red blood cells as well as platelets.